MedPath

Factors Determine the Feasibility and Surgical Margin Quality of Sublobar Resection for Non-small Cell Lung Cancer?

Completed
Conditions
Non-Small Cell Lung Cancer
Registration Number
NCT07005401
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Brief Summary

Sublobar resection (SR) has been recognized as non-inferior to lobectomy for small-sized non-small cell lung cancer (NSCLC). This study aimed to systematically identify the potential factors influencing the feasibility and surgical margin quality of SR for small-sized NSCLC.

Patients with small-sized NSCLC (≤2 cm) who underwent SR or lobectomy between 2020 and 2023 were screened. Surgical procedures were determined by discussion under the guidance of 3D-CTBA. A surgical margin ≥ the maximum tumor diameter was considered sufficient. SR with a sufficient surgical margin was considered eligible. Univariate and multivariate logistic regression analyses were performed to identify factors affecting the feasibility and margin quality of SR.

Detailed Description

Patients with small-sized pulmonary nodules who underwent lobectomy or SR between 2020 and 2023 in a single surgical team were retrospectively screened. All the surgical approach was jointly determined by three experienced surgeons (at least 15 years, Doctor Liang Chen, Weibing Wu and Zhicheng He). Patients satisfied with the following criteria were initially reserved: (1) the maximum nodule diameter ≤ 2 cm; (2) single malignant nodule; (3) intentional resection; (4) histopathological confirmed primary NSCLC. Further, patients with (1) interlobar lesions; (2) nodules in the right middle lobe; (3) receiving neoadjuvant before surgery; (4) poor CT quality were excluded.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1064
Inclusion Criteria
  • the maximum nodule diameter ≤ 2 cm
  • single malignant nodule
  • intentional resection
  • histopathological confirmed primary non-small cell lung cancer
Exclusion Criteria
  • interlobar lesions
  • nodules located in the right middle lobe
  • receiving neoadjuvant before surgery
  • poor CT quality were excluded

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
surgical margin qualityPerioperative

A surgical margin ≥ the maximum tumor diameter was considered sufficient.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The First Affiliated Hospital of Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

The First Affiliated Hospital of Nanjing Medical University
🇨🇳Nanjing, Jiangsu, China
© Copyright 2025. All Rights Reserved by MedPath